The NHS diabetic eye screening programme

2019 ◽  
Vol 13 (12) ◽  
pp. 596-599
Author(s):  
Ian Peate
Keyword(s):  
Healthy Lifestyle ◽  
False Negative ◽  
Young Person ◽  
Screening Process ◽  
Negative Results ◽  
Eye Screening ◽  
Increased Risk ◽  
Diabetic Eye Screening ◽  
The Individual ◽  
The Uk

The NHS diabetic eye screening (DES) programme is one of the young person and adult NHS population screening programmes that are available in the UK. The various NHS screening programmes identify those people who appear healthy, but could be at increased risk of a disease or condition. Screening is not the same as diagnosis and there will always be a possibility of some false positive and false negative results. This article in the series provides the reader with details about the DES programme. A brief overview of the anatomy of the eye is provided and the screening process is described. The healthcare assistant and assistant practitioner (HCA and AP) have a key role to play in encouraging and emphasising the importance of screening, as well as helping the individual maintain a healthy lifestyle.

The principles of a national diabetic eye screening programme

2020 ◽  
pp. 111-122
Author(s):  
Paul Galsworthy
Keyword(s):  
Public Health ◽  
Young Person ◽  
Population Based ◽  
National Standards ◽  
Evidence Based ◽  
Independent Evidence ◽  
Eye Screening ◽  
Increased Risk ◽  
Diabetic Eye Screening ◽  
The Uk

Screening identifies apparently healthy people who may be at increased risk of a disease or condition, enabling earlier treatment or better-informed decisions. The NHS diabetic eye screening (DES) programme is one of the young person and adult NHS population screening programmes in the UK. The UK National Screening Committee (UK NSC), which makes independent, evidence-based recommendations to ministers in the four UK nations about the 11 population-based screening programmes. Public Health England (PHE)—Screening Quality Assurance Service (SQAS) ensures programmes are safe and effective by ensuring national standards are met.

Impact of Patient Health Education on the Screening for Disease Test-Outcomes

2019 ◽  
pp. 156-189
Author(s):  
Thierry O. C. Edoh
Keyword(s):  
Medical Education ◽  
Healthy Lifestyle ◽  
False Negative ◽  
Health Condition ◽  
Screening Process ◽  
Significant Information ◽  
Patient Health ◽  
Information And Communication ◽  
Test Outcomes

Screening for diseases is a medical process to predict, prevent, detect, and cure a disease in people at high risk. However, it is limited in the quality and accuracy of the outcomes. The reason for this is the lack of long-term data about the health condition of the patient. Launching modern information and communication technology in the screening process has shown promise of improving the screening outcomes. A previous study has shown that patient education can positively impact the patient behavior face to a disease and can empower the patient to adopt a healthy lifestyle and thus avoid certain diseases. Offering medical education to the patient can positively impact screening outcomes since educated and empowered patients are more aware of certain diseases and can collect significant information. This can minimize the rate of false positive as well as false negative screening results. This chapter analyzes how medical education can contribute to improving screening outcomes.

Training and accreditation for retinal screening and grading

2020 ◽  
pp. 139-144
Author(s):  
Karen Whitehouse
Keyword(s):  
Slit Lamp ◽  
Slit Lamp Examination ◽  
Eye Screening ◽  
Current Requirement ◽  
Vocational Qualifications ◽  
Level 3 ◽  
Test Sets ◽  
Diabetic Eye Screening ◽  
The Uk ◽  
And Training

In all national screening programmes, staff training to confirm competency and accreditation to practice in their profession is required for patient safety. This chapter sets out an example of how the UK diabetic eye programme has evolved in this respect. The current National Vocational Qualifications (NVQ) level 3: Health screener: diabetic eye screening for personnel undertaking screening and grading, will be explained. In some programmes, slit lamp examination is now provided by graders, as well as ophthalmologists and optometrists. The current requirement is detailed. In addition, all grading staff should also participate in test and training of retinal image sets in order to confirm accuracy of grading. At least 10 test sets should be undertaken per annum.

False Positive and False Negative Radon Measurement Results Due to Uncertainties in Seasonal Correction Factors

1994 ◽  
Vol 56 (1-4) ◽  
pp. 291-292 ◽  
Author(s):  
K.D. Cliff ◽  
J.C.H. Miles ◽  
S.P. Naismith
Keyword(s):  
False Positive ◽  
False Negative ◽  
Geometric Standard Deviation ◽  
Correction Factors ◽  
Radon Measurement ◽  
Negative Results ◽  
False Negative Results ◽  
Initial Survey ◽  
The Uk ◽  
Radon Measurements

Abstract Data from the UK national survey of radon in 2300 homes has been re-analysed to determine the uncertainty in seasonal correction factors applied to measurements of less than l year. The required correction factor for each six-month result was calculated from the known annual average for the appropriate home. The seasonal correction factors derived for each month were found to be approximately log-normally distributed, with an average geometric standard deviation of 1.36. Following this initial survey, radon measurements have been made in more than 80,000 homes in southwest England to determine whether they are above the UK radon Action level of 200 Bq.m-3. The measurements were carried out over three months in each case using etched track detectors in two locations in each home, and the results were corrected for the average seasonal variation found in the original UK study of radon in homes. Because of the uncertainty in the seasonal correction factors, households with between 130 and 300 Bq.m-3 were advised to have a second three-month measurement in a different season before deciding whether or not to take remedial action. More than 7000 homes were remonitored for this purpose. The results are analysed to show the number of false positive and false negative results that would have been reported if advice had been based solely on the initial measurement. It is shown that the present scheme results in extremely small numbers of false positive and false negative results.

Impact of Patient Health Education on the Screening for Disease Test-Outcomes

2022 ◽  
pp. 370-396
Author(s):  
Thierry O. C. Edoh
Keyword(s):  
Medical Education ◽  
Healthy Lifestyle ◽  
False Negative ◽  
Health Condition ◽  
Screening Process ◽  
Significant Information ◽  
Patient Health ◽  
Information And Communication ◽  
Test Outcomes

Screening for diseases is a medical process to predict, prevent, detect, and cure a disease in people at high risk. However, it is limited in the quality and accuracy of the outcomes. The reason for this is the lack of long-term data about the health condition of the patient. Launching modern information and communication technology in the screening process has shown promise of improving the screening outcomes. A previous study has shown that patient education can positively impact the patient behavior face to a disease and can empower the patient to adopt a healthy lifestyle and thus avoid certain diseases. Offering medical education to the patient can positively impact screening outcomes since educated and empowered patients are more aware of certain diseases and can collect significant information. This can minimize the rate of false positive as well as false negative screening results. This chapter analyzes how medical education can contribute to improving screening outcomes.

scholarly journals Diagnosis of retinopathy in children younger than 12 years of age: implications for the diabetic eye screening guidelines in the UK

Eye ◽  
2016 ◽  
Vol 30 (7) ◽  
pp. 949-951 ◽  
Author(s):  
A Hamid ◽  
H M Wharton ◽  
A Mills ◽  
J M Gibson ◽  
M Clarke ◽  
...  
Keyword(s):  
Screening Guidelines ◽  
Eye Screening ◽  
Diabetic Eye Screening ◽  
The Uk

scholarly journals Helicobacter pylori: From Infection to Cure

1996 ◽  
Vol 10 (3) ◽  
pp. 167-172
Author(s):  
ABR Thomson
Keyword(s):  
Helicobacter Pylori ◽  
False Negative ◽  
Eradication Therapy ◽  
Erosive Esophagitis ◽  
Gastric Body ◽  
Negative Results ◽  
False Negative Results ◽  
Increased Risk ◽  
Major Interest ◽  
H Pylori

Over 380 abstracts, presentations and posters of recent advances were highlighted at the European and InternationalHelicobacter pylorimeeting held July 7 to 9, 1995 in Edinburgh, Scotland. New advances abound, with major interest focusing on the simple, safe, inexpensive new `gold standard’ forH pylorieradication therapy: a single week of tid omeprazole 20 mg, metronidazole 400 mg and clarithromycin 250 mg, or omeprazole 20 mg, amoxicillin 1000 mg and clarithromycin 500 mg. To avoid false negative results, two biopsies must be taken from the antrum and two from the gastric body at least four weeks after completion of eradication therapy, and ideally should be supplemented with at least one furtherH pyloritest such as a biopsy for urease activity or culture, or a urea breath test. While most patients with a gastric or duodenal ulcer (DU) who do not consume nonsteroidal anti-inflammatory drugs are infected withH pylori, the association is much less apparent in those with a DU who present with an upper gastrointestinal hemorrhage.H pylorieradication for nonulcer dyspepsia is not widely recommended, and the patient with a DU given effectiveH pylorieradication who presents with dyspepsia likely has erosive esophagitis rather than recurrent DU orH pylori. Gastroenterologists are at increased risk ofH pyloriinfection, particularly older gastroenterologists who are very busy endoscopists.

scholarly journals Effecting dietary change

2004 ◽  
Vol 63 (4) ◽  
pp. 537-547 ◽  
Author(s):  
Ashley J. Adamson ◽  
John C. Mathers
Keyword(s):  
Policy Development ◽  
Dietary Intervention ◽  
Dietary Habits ◽  
Healthy Lifestyle ◽  
Eating Behaviour ◽  
Dietary Change ◽  
Individual Level ◽  
Effective Strategies ◽  
The Individual ◽  
The Uk

A world epidemic of diet-related chronic disease is currently being faced. In the UK incidence of obesity alone has tripled in the last 20 years and this trend is predicted to continue. Consensus exists for the urgent need for a change in diet and other lifestyle factors and for the direction and targets for this change. The evidence for how this change can be achieved is less certain. It has been established that disease processes begin in childhood. Recent evidence indicates that dietary habits too are established in childhood but that these habits are amenable to change. While establishing a healthy lifestyle in childhood is paramount, interventions have the potential to promote positive change throughout the life course. Success in reversing current trends in diet-related disease will depend on commitment from legislators, health professionals, industry and individuals, and this collaboration must seek to address not only the food choices of the individual but also the environment that influences such choices. Recent public health policy development in England, if fully supported and implemented, is a positive move towards this goal. Evidence for effective strategies to promote dietary change at the individual level is emerging and three reviews of this evidence are discussed. In addition, three recent dietary intervention studies, in three different settings and with different methods and aims, are presented to illustrate methods of effecting dietary change. Further work is required on what factors influence the eating behaviour and physical activity of individuals. There is a need for further theory-based research on which to develop more effective strategies to enable individuals to adopt healthier lifestyles.

scholarly journals A Rapid and Low-Cost protocol for the detection of B.1.1.7 lineage of SARS-CoV-2 by using SYBR Green-Based RT-qPCR

2021 ◽  
Author(s):  
Fadi Abdel Sater ◽  
Mahmoud Younes ◽  
Hassan Nassar ◽  
Paul Nguewa ◽  
Kassem Hamze
Keyword(s):  
Low Cost ◽  
False Negative ◽  
Sybr Green ◽  
Reproductive Number ◽  
Rt Pcr ◽  
Negative Results ◽  
False Negative Results ◽  
New Variant ◽  
Primer Sets ◽  
The Uk

AbstractBackgroundThe new SARS-CoV-2 variant VUI (202012/01), identified recently in the United Kingdom (UK), exhibits a higher transmissibility rate compared to other variants, and a reproductive number 0.4 higher. In the UK, scientists were able to identify the increase of this new variant through the rise of false negative results for the spike (S) target using a three-target RT-PCR assay (TaqPath kit).MethodsTo control and study the current coronavirus pandemic, it is important to develop a rapid and low-cost molecular test to identify the aforementioned variant. In this work, we designed primer sets specific to SARS-CoV-2 variant VUI (202012/01) to be used by SYBR Green-based RT-PCR. These primers were specifically designed to confirm the deletion mutations Δ69/Δ70 in the spike and the Δ106/Δ107/Δ108 in the NSP6 gene. We studied 20 samples from positive patients, 16 samples displayed an S-negative profile (negative for S target and positive for N and ORF1ab targets) and four samples with S, N and ORF1ab positive profile.ResultsOur results emphasized that all S-negative samples harbored the mutations Δ69/Δ70 and Δ106/Δ107/Δ108. This protocol could be used as a second test to confirm the diagnosis in patients who were already positive to COVID-19 but showed false negative results for S-gene.ConclusionsThis technique may allow to identify patients carrying the VUI (202012/01) variant or a closely related variant, in case of shortage in sequencing.

Leveraging technology to facilitate distress screening.

2017 ◽  
Vol 35 (8_suppl) ◽  
pp. 195-195
Author(s):  
Susan Franco ◽  
Dawn Jourdan
Keyword(s):  
Multidisciplinary Team ◽  
Screening Tool ◽  
Screening Program ◽  
Case Manager ◽  
Distress Screening ◽  
Screening Process ◽  
Distress Score ◽  
Increased Risk ◽  
Oncology Practice ◽  
The Individual

195 Background: Research has shown cancer patients are at increased risk for distress during their cancer treatment. Distress screening is required for cancer programs seeking accreditation from the American College of Surgeons, Commission on Cancer and certification from the American Society of Clinical Oncology Quality Oncology Practice Initiative. Developing a successful distress screening program is essential for cancer programs. Methods: The purpose of this project was to create a comprehensive distress screening program utilizing the electronic health record (EHR) to identify patients requiring screening and document interventions. A multidisciplinary team was established to develop a distress screening process for our cancer program. The team developed a screening tool based on the National Comprehensive Cancer Network Distress Thermometer. The distress screening tool was built into the EHR. An alert was created to notify staff at visit check-in to provide the distress screening tool. Once completed, the score and any areas of distress indicated by the patient are entered into the EHR by the medical assistant. When a score is documented, the nurse case manager (CM) receives a “Distress Score” alert when accessing the patient’s chart, indicating the need for nursing review. The CM reviews the score, assesses patient needs and documents any needed interventions or referrals. A specific score does not require a specific intervention, rather the CM is required to determine the needs of the individual patient and take appropriate action. Results: In 2015, 8069 patients were offered distress screening with 13,527 distress screenings completed. This resulted in 629 referrals to social work. 803 distress screens had a score of seven or greater (6%). Conclusions: The multidisciplinary team continues to evaluate the process and make changes. Auditing reveals compliance with documenting a distress score of 95% or greater across all oncology areas and review by the CM of at least 93% on a consistent basis. In many instances, the physician and/or the CM address distress related to the patient’s disease or symptom management. Use of the EHR has facilitated the workflow and allowed information to be visible to the care team.

Sign in / Sign up

Export Citation Format

Share Document